Related Experiment Videos
Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole
W S Saari1, J E Schwering, P A Lyle
1Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
Journal of Medicinal Chemistry
|January 1, 1990
Summary
New prodrugs release active compounds via a predictable chemical reaction, not enzymes. These basic carbamates of 4-hydroxyanisole offer a novel approach to drug delivery.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Pharmacology
Background:
- 4-hydroxyanisole is a melanocytotoxic phenol.
- Basic carbamates can serve as prodrugs.
- Prodrug activation often relies on enzymatic cleavage.
Purpose of the Study:
- To synthesize and evaluate basic carbamates of 4-hydroxyanisole as prodrugs.
- To investigate the release kinetics of 4-hydroxyanisole from these carbamates.
- To characterize the mechanism of prodrug activation.
Main Methods:
- Synthesis of a series of basic carbamates of 4-hydroxyanisole.
- Stability studies at varying pH levels.
- Kinetic analysis of 4-hydroxyanisole release at pH 7.4 and 37°C.
- Identification of reaction byproducts.
Main Results:
- Carbamates were stable at low pH but released 4-hydroxyanisole at pH 7.4.
- Release rates were dependent on carbamate structure.
- N-methyl-N-[2-(methylamino)ethyl]carbamate released 4-hydroxyanisole via first-order kinetics (t1/2 = 36.3 min).
- N,N'-dimethylimidazolidinone was identified as a byproduct.
Conclusions:
- Basic carbamates of 4-hydroxyanisole function as cyclization-activated prodrugs.
- Prodrug activation is achieved through an intramolecular cyclization-elimination reaction, independent of enzymatic activity.
- This mechanism offers a predictable and controllable method for drug release.